Effect of TNF priming of murine peritoneal macrophages on their activation to a tumoricidal state

Rakesh Kumar Singh, Ajit Sodhi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Murine peritoneal macrophages, on treatment with TNF (10 U/ml) for various durations, showed enhanced cytotoxicity against tumor target cells. The macrophage-mediated cytotoxicity was significantly enhanced when TNF-primed macrophages were treated with cisplatin, LPS, FK-565 or interferon-gamma for 24 h, compared to unprimed and treated macrophages. TNF-primed macrophages also showed enhanced expression of interleukin-1 and tumor necrosis factor activities on activation with different biological response modifiers.

Original languageEnglish (US)
Pages (from-to)127-133
Number of pages7
JournalImmunology Letters
Volume28
Issue number2
DOIs
StatePublished - May 1991

Fingerprint

Peritoneal Macrophages
Macrophages
Immunologic Factors
Interleukin-1
Cisplatin
Interferon-gamma
Tumor Necrosis Factor-alpha
Neoplasms

Keywords

  • Activation
  • Cisplatin
  • FK-565
  • IL-1
  • Interferon-γ
  • Lipopolysaccharide
  • Macrophage
  • TNF priming

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Effect of TNF priming of murine peritoneal macrophages on their activation to a tumoricidal state. / Singh, Rakesh Kumar; Sodhi, Ajit.

In: Immunology Letters, Vol. 28, No. 2, 05.1991, p. 127-133.

Research output: Contribution to journalArticle

@article{92bd8e05895a45db91be9bedffe40623,
title = "Effect of TNF priming of murine peritoneal macrophages on their activation to a tumoricidal state",
abstract = "Murine peritoneal macrophages, on treatment with TNF (10 U/ml) for various durations, showed enhanced cytotoxicity against tumor target cells. The macrophage-mediated cytotoxicity was significantly enhanced when TNF-primed macrophages were treated with cisplatin, LPS, FK-565 or interferon-gamma for 24 h, compared to unprimed and treated macrophages. TNF-primed macrophages also showed enhanced expression of interleukin-1 and tumor necrosis factor activities on activation with different biological response modifiers.",
keywords = "Activation, Cisplatin, FK-565, IL-1, Interferon-γ, Lipopolysaccharide, Macrophage, TNF priming",
author = "Singh, {Rakesh Kumar} and Ajit Sodhi",
year = "1991",
month = "5",
doi = "10.1016/0165-2478(91)90110-V",
language = "English (US)",
volume = "28",
pages = "127--133",
journal = "Immunology Letters",
issn = "0165-2478",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Effect of TNF priming of murine peritoneal macrophages on their activation to a tumoricidal state

AU - Singh, Rakesh Kumar

AU - Sodhi, Ajit

PY - 1991/5

Y1 - 1991/5

N2 - Murine peritoneal macrophages, on treatment with TNF (10 U/ml) for various durations, showed enhanced cytotoxicity against tumor target cells. The macrophage-mediated cytotoxicity was significantly enhanced when TNF-primed macrophages were treated with cisplatin, LPS, FK-565 or interferon-gamma for 24 h, compared to unprimed and treated macrophages. TNF-primed macrophages also showed enhanced expression of interleukin-1 and tumor necrosis factor activities on activation with different biological response modifiers.

AB - Murine peritoneal macrophages, on treatment with TNF (10 U/ml) for various durations, showed enhanced cytotoxicity against tumor target cells. The macrophage-mediated cytotoxicity was significantly enhanced when TNF-primed macrophages were treated with cisplatin, LPS, FK-565 or interferon-gamma for 24 h, compared to unprimed and treated macrophages. TNF-primed macrophages also showed enhanced expression of interleukin-1 and tumor necrosis factor activities on activation with different biological response modifiers.

KW - Activation

KW - Cisplatin

KW - FK-565

KW - IL-1

KW - Interferon-γ

KW - Lipopolysaccharide

KW - Macrophage

KW - TNF priming

UR - http://www.scopus.com/inward/record.url?scp=0025891003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025891003&partnerID=8YFLogxK

U2 - 10.1016/0165-2478(91)90110-V

DO - 10.1016/0165-2478(91)90110-V

M3 - Article

C2 - 1909301

AN - SCOPUS:0025891003

VL - 28

SP - 127

EP - 133

JO - Immunology Letters

JF - Immunology Letters

SN - 0165-2478

IS - 2

ER -